ADVANCED SOLID TUMOR HISTORICALLY KNOWN FOR HIGH EPHA2 EXPRESSION

Clinical trials for ADVANCED SOLID TUMOR HISTORICALLY KNOWN FOR HIGH EPHA2 EXPRESSION explained in plain language.

Never miss a new study

Get alerted when new ADVANCED SOLID TUMOR HISTORICALLY KNOWN FOR HIGH EPHA2 EXPRESSION trials appear

Sign up with your email to follow new studies for ADVANCED SOLID TUMOR HISTORICALLY KNOWN FOR HIGH EPHA2 EXPRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New targeted drug enters human trials for Tough-to-Treat cancers

Disease control Ongoing

This early-stage study is testing a new drug called BT5528 in people with advanced solid tumors that have spread or returned. The main goals are to find a safe dose, understand the side effects, and see if the drug shows early signs of helping to control cancers like ovarian, lun…

Matched conditions: ADVANCED SOLID TUMOR HISTORICALLY KNOWN FOR HIGH EPHA2 EXPRESSION

Phase: PHASE1, PHASE2 • Sponsor: BicycleTx Limited • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

ADVANCED SOLID TUMOR HISTORICALLY KNOWN FOR HIGH EPHA2 EXPRESSION

Get alerted when new ADVANCED SOLID TUMOR HISTORICALLY KNOWN FOR HIGH EPHA2 EXPRESSION trials appear

New targeted drug enters human trials for Tough-to-Treat cancers